Maravai LifeSciences completed the acquisition of Alphazyme.

Synopsis

Maravai LifeSciences, a life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines, completed the acquisition of Alphazyme, an OEM provider of custom, scalable molecular biology enzymes. Financial terms were not disclosed.

Principals

target

Alphazyme

bidder

Maravai Lifesciences

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context